United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise
Rhea-AI Filing Summary
United Therapeutics Chairperson & CEO Martine A. Rothblatt reported that family trusts with which she shares investment power exercised 9,500 stock options at an exercise price of $135.42 per share and sold 9,500 shares of common stock on July 24, 2026 at weighted-average prices between approximately $528 and $535 per share, pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025.
Following the exercise, the trusts continue to hold 274,910 stock options from this grant expiring March 15, 2027, and Rothblatt also directly owns 40,513 common shares. The trading plan will continue until the earlier of the exercise of up to 1,734,410 stock options or December 31, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.77M approx. pre-tax spread)
Exercise and Sale
14 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($5.05M)
Approx. gross sale proceeds
$5.05M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.77M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F13 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 820 | $528.718 | $434K |
| Sale | Common Stock F1, F4, F2 | 2,285 | $530.4506 | $1.21M |
| Sale | Common Stock F1, F5, F2 | 1,115 | $531.1021 | $592K |
| Sale | Common Stock F1, F6, F2 | 2,719 | $532.2653 | $1.45M |
| Sale | Common Stock F1, F7, F2 | 1,818 | $533.1991 | $969K |
| Sale | Common Stock F1, F8, F2 | 630 | $534.3938 | $337K |
| Sale | Common Stock F1, F9, F2 | 113 | $535.0256 | $60K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F10 | -- | -- | -- |
| holding | Common Stock F11 | -- | -- | -- |
| holding | Common Stock F12 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 274,910 shares (Indirect, by Trust);
Common Stock — 582,453 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 45,762 shares (Indirect, by Spouse)
Footnotes (13)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F11. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F12. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F13. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $528.16 to $528.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $529.705 to $530.70. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $530.72 to $531.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $531.74 to $532.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $532.77 to $533.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $533.88 to $534.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $534.89 to $535.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Options exercised: 9,500 shares at $135.4200
Shares sold: 9,500 shares
Remaining options in trust: 274,910
+2 more
5 metrics
Options exercised
9,500 shares at $135.4200
Stock options exercised indirectly by a family trust on 2026-07-24
Shares sold
9,500 shares
Common stock sold in multiple transactions on 2026-07-24 at weighted-average prices around $528–$535
Remaining options in trust
274,910
Stock options held by a family trust after the reported option exercise
Direct common shares
40,513 shares
Common stock held directly by Martine A. Rothblatt after the transactions
10b5-1 plan option capacity
1,734,410 stock options
Maximum options to be exercised under the trading plan before March 15, 2027 or December 31, 2026
Key Terms
pre-arranged 10b5-1 trading plan, weighted average price, stock options, family trusts, +1 more
5 terms
pre-arranged 10b5-1 trading plan regulatory
"This exercise of stock options and sale...was pursuant to a pre-arranged 10b5-1 trading plan"
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
stock options financial
"This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options..."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
family trusts financial
"Shares held in family trusts as to which the Reporting Person shares investment power..."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did UTHR CEO Martine Rothblatt report on July 24, 2026?
Martine A. Rothblatt reported that family trusts exercised 9,500 stock options at $135.42 per share and sold 9,500 UTHR common shares in multiple transactions on July 24, 2026 at weighted-average prices between roughly $528 and $535 per share.
Were the July 24, 2026 UTHR insider trades made under a Rule 10b5-1 plan?
Yes. The option exercise and resulting UTHR share sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Martine A. Rothblatt on November 7, 2025, as disclosed in the filing footnotes.
What is the scope and duration of Martine Rothblatt’s 10b5-1 plan for UTHR options?
The Rule 10b5-1 plan covers potential exercise of up to 1,734,410 stock options, all expiring on March 15, 2027. The plan will continue until the earlier of exercising those options or December 31, 2026.